What We're Reading: Page 245
Industry reads hand-picked by our editors
May 10, 2019
-
The Wall Street Journal
U.S. Slaps Higher Tariffs on Chinese Imports as Trade Talks Resume
-
Minneapolis Star Tribune
Medtronic shuts division aimed at offering lower-cost orthopedic implants
-
Medical Design & Outsourcing
Federal judge boots Sterigenics suit to state court
-
MassDevice
Judge: Ex-Abbott worker can’t sue twice
-
Healthcare Dive
Phishing, device insecurity biggest vulnerabilities for healthcare organizations
May 09, 2019
-
The New York Times
Elizabeth Holmes’s Possible Defense in Theranos Case: Put the Government on Trial
-
MobiHealthNews
Lilly-funded study shows Livongo diabetes can save employers $20 to $50 per member per month
-
Medtech Insight
Opinion: Wilkinson’s October Departure From UK MHRA – Should We Be Concerned?
-
Diagnostic and Interventional Cardiology
Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
May 08, 2019
-
Bloomberg
J&J Pays About $1 Billion to Resolve Pinnacle-Hip Suits
-
Healthcare Dive
NIH offers first glimpse of All of Us health database via interactive tool
-
The New York Times
Robert Pear, Who Covered Washington for 45 Years, Dies at 69
-
Healthcare Dive
Aetna launches app for Apple Watch
May 07, 2019
-
Business Insider
Microbiome-testing company uBiome has suspended its medical tests following an FBI raid
-
CNBC
More young adults in the US are dying from heart failure, study finds
-
ProPublica
The Birth-Tissue Profiteers
-
The Advocate
Louisiana prisons pilot addiction-fighting implants for inmates; lack of FDA approval draws criticism
May 06, 2019
-
NPR
How Helpful Would A Genetic Test For Obesity Risk Be?
-
The New York Times
80,000 Deaths. 2 Million Injuries. It’s Time for a Reckoning on Medical Devices.
-
Reuters
U.S. doctors use medical records to fight measles outbreak
-
The Washington Post
Spotlight shifts to Johnson & Johnson as first major opioid trial nears in Oklahoma
May 03, 2019
-
The Sydney Morning Herald
Resmed back on track after better-than-expected third quarter
-
CNBC
Insiders describe aggressive growth tactics at uBiome, the health start-up raided by the FBI last week
-
Medtech Insight
‘Disease Doesn’t Respect Silos’: Sharpless Sets Flexibility As Priority
-
MassDevice
Teleflex shares rise on Street-beating Q1
Previous
